Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
28.9%
% of CANC's 45 holdings also in SBIO
15.1%
% of SBIO's 87 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 3.1% | 3.1% | 3.1% |
|
CELLDEX THERAPEUTICS INC | 2.6% | 1.7% | 1.7% |
 |
MERUS N.V. | 1.7% | 1.6% | 1.6% |
|
INTELLIA THERAPEUTICS, INC. | 1.8% | 1.6% | 1.6% |
|
ARVINAS, INC. | 1.4% | 1.8% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to SBIO
|
MERCK & CO. INC. | 5.6% |
|
REGENERON PHARMACEUTICALS | 5.6% |
 |
DAIICHI SANKYO CO LTD | 4.0% |
 |
ASTRAZENECA PLC | 3.8% |
 |
NOVARTIS AG | 3.7% |
|
ILLUMINA INC | 3.5% |
|
EXACT SCIENCES CORP | 3.1% |
 |
ARGENX SE ADR | 2.9% |
|
GILEAD SCIENCES INC | 2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | 2.7% |
CANC Underweight Relative to SBIO
|
VIKING THERAPEUTICS, INC. | -5.3% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% |
|
VAXCYTE, INC. | -4.6% |
 |
ALKERMES PLC | -2.8% |
|
AXSOME THERAPEUTICS, INC. | -2.3% |
|
CRINETICS PHARMACEUTICALS INC | -2.1% |
|
XENON PHARMACEUTICALS INC. | -2.0% |
|
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -1.9% |
|
ACADIA PHARMACEUTICALS INC | -1.8% |
|
DENALI THERAPEUTICS INC. | -1.7% |